OAC Newsroom

Obesity Action Coalition Thanks the Biden Administration for Proposed Expansion of Obesity Medication Coverage
in OAC Blog, OAC Newsroom on November 26, 2024

FOR IMMEDIATE RELEASE: Tampa, FL — October 18, 2024 — This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding access to obesity medications for Americans with Medicare and Medicaid coverage. “This is incredible. For more than a decade, the OAC, alongside partner
Read Article

OAC and Eli Lilly and Company Partner to Launch Bias-Free Obesity Image Gallery at HLTH 2024
in 2024 New Releases, News Releases, OAC Newsroom on October 18, 2024

FOR IMMEDIATE RELEASE: Tampa, FL — October 18, 2024 — The Obesity Action Coalition (OAC) is proud to announce the launch of its bias-free obesity image gallery, produced in partnership with Eli Lilly and Company, at the 2024 HLTH Conference taking place October 20-23. This initiative, part of OAC’s Stop Weight Bias Campaign, provides a
Read Article

Obesity Action Coalition (OAC) Responds to New CDC Obesity Maps, Calls for Expanded Access to Care
in 2024 New Releases, News Releases, OAC Blog, OAC Newsroom on September 12, 2024

FOR IMMEDIATE RELEASE: Tampa, FL — September 12, 2024 — The Obesity Action Coalition (OAC) today responded to the Centers for Disease Control and Prevention’s (CDC) newest data on obesity prevalence in the United States, which shows 23 states now reporting that more than one in three adults is living with obesity. “The CDC’s report
Read Article

Obesity Action Coalition (OAC) Unveils New PSA to Encourage Conversations About Weight and Health
in 2024 New Releases, News Releases, OAC Blog, OAC Newsroom on

September 10, 2024 Tampa, FL — September 10, 2024 — The Obesity Action Coalition (OAC) has launched a new Public Service Announcement (PSA) as part of its nationally recognized Your Weight Matters Campaign, aiming to encourage millions of Americans to take control of their health by starting a vital conversation with their healthcare provider. With
Read Article

Obesity Action Coalition (OAC) Applauds Biden Administration’s Efforts to Increase Access to Obesity Care
in 2024 New Releases, News Releases, OAC Blog, OAC Newsroom on August 29, 2024

Tampa, Fla. — The Obesity Action Coalition (OAC) commends the Biden Administration for raising awareness of the need to expand access to obesity care and reduce the high cost of obesity medications. President Biden’s recent announcement marks a significant step forward in a national effort to enhance care and support for individuals affected by obesity.
Read Article

Obesity Action Coalition Applauds the House Ways and Means Committee for Advancing the Treat and Reduce Obesity Act
in 2024 New Releases, OAC Blog, OAC Newsroom on June 27, 2024

Tampa, Fla., June 27, 2024 – The Obesity Action Coalition (OAC) applauds the House Ways and Means Committee for favorably reporting an amended version of the Treat and Reduce Obesity Act with a strong bipartisan vote of 36-4. This significant milestone reflects a commitment from key lawmakers in the House to expand access to obesity
Read Article

Welcome, Madrigal Pharmaceuticals, Inc., to the Obesity Action Coalition’s Chairman’s Council!
in OAC Blog, OAC Newsroom on June 12, 2024

The Obesity Action Coalition (OAC) is pleased to share that Madrigal Pharmaceuticals, Inc. has joined OAC’s Chairman’s Council at the Bronze level! Thank you for committing to supporting and championing the OAC’s mission. About Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with
Read Article

Obesity Action Coalition and STOP Obesity Alliance Collaborate on new Medicaid Obesity Treatment Coverage Research
in 2024 New Releases, OAC Blog, OAC Newsroom on June 3, 2024

Tampa, Fla., June 3, 2024—The Obesity Action Coalition (OAC) and the STOP Obesity Alliance are proud to announce the release of the “Medicaid Obesity Treatment Coverage Study.” This study is the first to analyze and investigate levels of state Medicaid coverage for obesity treatment options, beyond whether a benefit was covered or not. Healthcare plans
Read Article

50+ Patient & Provider Groups Urge the Biden Administration to Provide Comprehensive Care for Obesity
in 2024 New Releases, OAC Blog, OAC Newsroom on May 28, 2024

Tampa, FL, May 28, 2024 – This week, the Obesity Action Coalition (OAC), along with 57 other organizations, delivered a letter to the Biden Administration to call on the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) to provide access to comprehensive obesity care. The letter to
Read Article

Welcome, Boston Scientific, to the Obesity Action Coalition’s Chairman’s Council
in OAC Blog, OAC Newsroom on May 15, 2024

The Obesity Action Coalition (OAC) is pleased to share that Boston Scientific has joined OAC’s Chairman’s Council at the Silver level! Thank you for committing to support and champion the OAC’s mission. About Boston Scientific As a global medical technology leader for more than 40 years, Boston Scientific transforms lives through innovative medical technologies that improve the health
Read Article

Welcome, Biohaven Pharmaceuticals, to the Obesity Action Coalition’s Chairman’s Council
in OAC Blog, OAC Newsroom on May 13, 2024

The Obesity Action Coalition (OAC) is pleased to share that Biohaven Pharmaceuticals has joined OAC’s Chairman’s Council at the Bronze level! Thank you for committing to support and champion the OAC’s mission. About Biohaven Pharmaceuticals Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including
Read Article

Obesity Action Coalition Urges CMS to Expand Coverage to Obesity Medications
in OAC Blog, OAC Newsroom on April 24, 2024

The Obesity Action Coalition, the Partnership to Advance Cardiovascular Health and more than 40 healthcare and advocacy organizations are urging the Centers for Medicare & Medicaid Services (CMS) to expand coverage and access to semaglutide for the treatment of obesity. We applaud CMS’s recent decision to cover obesity medications for patients with existing, high-risk cardiovascular
Read Article